SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

Cellectar Biosciences Q1 EPS $(0.420) Up From $(0.760) YoY

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.420) per share. This is a 44.74 percent increase over losses of $(0.760) per share from the same period last year.

Benzinga · 05/07/2020 12:45

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.420) per share. This is a 44.74 percent increase over losses of $(0.760) per share from the same period last year.